Cannatrek has announced plans to launch Organicraft, its own Australian-grown range of plant-based medicine grown in certified organic soil. Soil beds have recently been commissioned and installed at Cannatrek’s Brisbane cultivation facility, and Cannatrek has recently completed successful testing of product batches that were grown in soil and tested alongside the same cultivars that were being grown in hydroponic media. New Cannatrek products from the “Mazar” cultivar and the “Banana Durban Gushers” cultivar were both part of these trials.
The Cannatrek cultivation team believe that soil-grown flower surpasses the quality of anything grown at their Queensland facility to date. When harvested from both hydroponic and soil media, the flower from the “Mazar” cultivar presents as a unique product with aromatic notes of caramel, toast, and maple syrup. The flower from the “Banana Durban Gushers” cultivar expresses dominant notes of sweet fuel and pine nuances. The team observed that terpene diversity is increased in flower harvested from soil, and they are excited to start seeing more cultivars tested through soil media in the future. Cannatrek has elected to begin commercial plantings with a new, previously unreleased cultivar – “Chocolope,” which has an inviting bouquet of chocolate and melon. Cannatrek has successfully tested these strains in an organic living soil environment irrigated with rainwater, achieving excellent terpene results that will be considered for future commercial cultivation programs.
The cultivation and harvest teams have also recently converted the Brisbane facility to a 100% hang-dried and dry-trimmed harvest and processing method from what was previously a wet-trim and rack-dry process. Similarly to the soil grow testing, hang-dried flower has indicated higher terpene levels and broader terpene diversity.
The Organicraft range of premium flower medicine will be grown in organic living soil and hang-dried. It will become one of Australia’s first fully organic, GMP-compliant, plant-based medicine ranges.
Cannatrek CEO Tommy Huppert says Cannatrek is committed to ensuring high-quality, Australian-grown, plant-based medicine is accessible to the market, to support the quality of life of patients, foster sustainable cultivation practices, and reducing the carbon footprint of the healthcare industry.